Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy

Clinical trial NCT06586242 · RECRUITING

Trial details

NCT number: NCT06586242
Sponsor: Xijing Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2023-04-03
Primary completion: 2025-04-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.